Skip to main content
Monday
September 22, 2025
Sign In
Subscribe
Latest
Economy
Banking
Stocks
Industry
Analysis
Bazaar
RMG
Corporates
Aviation
Videos
TBS Today
TBS Stories
TBS World
News of the day
TBS Programs
Podcast
Editor's Pick
World+Biz
Features
Panorama
The Big Picture
Pursuit
Habitat
Thoughts
Splash
Mode
Tech
Explorer
Brands
In Focus
Book Review
Earth
Food
Luxury
Wheels
Subscribe
Get the Paper
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Magazine
Climate Change
Health
Cartoons
বাংলা
MONDAY,
SEPTEMBER 22, 2025
COVAXIN
COVAXIN
Indian drug regulator okays Covaxin for 6-12 year olds, Corbevax for 5-12 bracket
Bharat Biotech on WHO's Covaxin supply suspension: No impact on efficacy, safety
WHO suspends Covaxin supplies under UN procurement
India gives conditional market nod for Covishield and Covaxin
India's Bharat Biotech says Covaxin booster shot neutralises Omicron
Covaxin 77.8% effective against Covid-19 in Lancet study
UK to add China's Sinovac, India's Covaxin to approved vaccine list
After WHO nod, travellers vaccinated with Covaxin allowed to enter US from Nov 8
WHO issues emergency use listing for COVAXIN Covid-19 jab
Review of India's Covaxin shot underway, WHO says
Better immune response from mixing Covaxin, Covishield, says ICMR study
Covishield output to be increased to 120 million, Covaxin to 58 million: Govt
Indian Covaxin to be permitted for trial in Bangladesh
Show More